Y-MABS THERAPEUTICS, INC. SHAREHOLDERS HAVE AN OPPORTUNITY TO RECOVER THEIR INVESTMENT LOSSES
Y-mAbs Therapeutics, Inc.
Certification and Authorization of Plaintiff Pursuant to Federal Securities Laws
The individual or entity listed below (the "Plaintiff") authorizes and, upon execution of the accompanying retainer agreement by Bernstein Liebhard LLP, retains Bernstein Liebhard LLP to file an action under the federal securities laws to recover damages and to seek other relief against Y-mAbs Therapeutics, Inc. . Bernstein Liebhard LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses. The Y-mAbs Therapeutics, Inc. Retention Agreement provided to the Plaintiff is incorporated by reference, upon execution by Bernstein Liebhard LLP.